Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53656

言語	英語
著者	Mitsui Yozo 1 Department of Urology, Shimane University Faculty of Medicine, Enya-cho, Izumo, Japan 2 Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Hirata Hiroshi Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Arichi Naoko Department of Urology, Shimane University Faculty of Medicine, Enya-cho, Izumo, Japan 平木美穂安本博晃 Chang Inik Department of Oral Biology, Yonsei University College of Densitry, Seoul, South Korea Fukuhara Shinichiro Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan Yamamura Soichiro Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Shahryari Varahram Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Deng Guoren Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Saini Sharanjot Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Majid Shahana Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Dahiya Rajvir Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA Tanaka Yuichiro Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA 椎名浩昭
主題	bone morphogenetic protein 2; renal cell carcinoma; DNA methylation; molecular marker
掲載誌名	ONCOTARGET
巻	6
号	11
開始ページ	9577
終了ページ	9591
ISSN（Online）	1949-2553
発行日	2015-04-20
DOI	10.18632/oncotarget.3445
PubMed ID	25797254
出版者	IMPACT JOURNALS LLC
資料タイプ	学術雑誌論文
部局	医学部
備考	Address all correspondence and requests for Yozo Mitsui, MD, PhD, Departments of Urology, Shimane University Faculty of Medicine, 89-1 Enya-cho, 693-8501 Izumo, Japan. E-mail: mitsui@med.shimane-u.ac.jp. We thank Dr. Roger Erickson for his support and assistance with the preparation of the manuscript. This research study was supported by the National Center for Research Resources of the NIH through Grant Number RO1CA130860 and VA Merit Review and VA Program Project.